This content is machine translated Valérie Krafft, Executive Director of the Rheumatism League Switzerland: “Rheumatic diseases still meet with a lot of misunderstanding from the public” The Swiss Rheumatism League has been working for people with rheumatism since 1958. In an interview, Executive Director Valérie Krafft explains how the non-profit organization supports those affected, why the…
View Post 5 min This content is machine translated The metabolic patient Type 2 diabetes: reducing cardiovascular risk through lipid lowering Diabetes is associated with increased cardiovascular risk. Multifactorial therapy of the four major risk factors of blood glucose, weight, hypertension, and dyslipidemia in individuals with type 2 diabetes is challenging.…
View Post 3 min This content is machine translated Type 2 diabetics with overweight Dulaglutide in higher dosage additionally promotes weight reduction GLP-1 receptor agonists not only improve glycemic control but also support weight loss and have also demonstrated additional cardio- and neprotective benefits. Dulaglutide (s.c.) has been successfully used for the…
View Post 1 min This content is machine translated Podcast Extraintestinal manifestations and comorbidities Manifestations outside the gatrointestinal tract can additionally have a massive impact on the quality of life of IBD patients. Multidisciplinary collaboration is essential for effective treatment. The treatment spectrum available…
View Post 1 min This content is machine translated Data put in perspective Five years of ustekinumab in Crohn’s disease Long-term data confirm safety and efficacy of ustekinumab: The UNITI study evaluated the efficacy and safety of intravenous induction therapy with ustekinumab followed by subcutaneous maintenance therapy and an extension phase…
View Post 4 min This content is machine translated SUSTAIN-10: Post-hoc analysis Semaglutide and liraglutide in type 2 diabetes: effective and safe with and without SGLT-2-i Based on empirical evidence, professional societies recommend early combination of metformin with an SGLT-2 inhibitor or a GLP-1 receptor agonist in type 2 diabetics. Increasingly, a combined application of the…
View Post 3 min This content is machine translated Psoriasis: disease management during corona pandemic “Shared decision making” is especially important in these times Among psoriasis patients, there is often some uncertainty about the implications of their underlying disease and the respective system therapy with regard to the risk of a severe course of…
View Post 4 min This content is machine translated Comorbidity Research Psoriasis as a systemic disease – study findings on comorbid depression Psoriasis and psoriatic arthritis (PsoA) often have a significant impact on the daily life and quality of life of those affected. The prevalence of mental health comorbidities is increased, with…
View Post 4 min This content is machine translated Acute myeloid leukemia (AML) “A new standard of care for elderly and fragile patients” A BCL-2 inhibitor is convincing in new studies in the first-line treatment of AML patients who are not suitable for intensive chemotherapy [1]. Hematologists Dr. Georgios Georgiou and Prof. Photis…
View Post 5 min This content is machine translated Interview with Prof. Dr. med. Pascal Richette Facing the challenges of psoriatic arthritis management Despite remarkable progress in the treatment of patients with psoriatic arthritis (PsA), the management of this chronic disease still poses major challenges [1]. In the following interview, Prof. Pascal Richette,…
View Post 2 min This content is machine translated Osteoporosis in Motion CME video training on osteoporosis management Osteoporosis and, as a consequence, osteoporotic fractures are highly prevalent, especially in postmenopausal women, and are often associated with serious health, social, and economic consequences. CME-Test
